A new ultrasound technology from Toshiba America Medical Systems is improving micro-vascular imaging by allowing physicians to better visualize tiny blood vessels in and around regions such as tumors and lymph nodes.
Recently cleared by the FDA for use on Toshiba’s Aplio 500 ultrasound system, Superb Micro-Vascular Imaging (SMI) improves time to diagnosis and offers an alternative to contrast agents and more invasive procedures. The new development was recently on display at the Society of Vascular Ultrasound (SVU) annual conference August 6-9 in Lake Buena Vista, Fla.
“Toshiba ultrasound continues to push the envelope,” said Tomohiro Hasegawa, director of Toshiba’s ultrasound business unit. “With the development of SMI, clinicians can provide the right diagnosis on all patients earlier for improved care. Additionally, SMI expands the utility of ultrasound, which results in fewer ionizing procedures, improving patient safety.”
For more information, visit Toshiba America Medical Systems.
